Filing Flows › Jupiter Neurosciences (JUNS) › Q1 2026
Jupiter Neurosciences (JUNS) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 14, 2026
Jupiter Neurosciences (JUNS) reported revenue of $19K for the first quarter 2026 (Q1 2026).
Revenue$19K
Year over year—
Quarter over quarter—
Operating margin—
Net earnings−$2.1M
Jupiter Neurosciences, Q1 2026: revenue $19K, net loss $2.1M, operating cash flow −$1.4M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $19K | — | — |
| Operating profit | −$2.0M | — | — |
| Net earnings | −$2.1M | — | — |
| Operating cash flow | −$1.4M | — | — |
What changed
Revenue was $19K in Q1 2026.
Gross margin was 76.6%. Operating costs exceeded revenue by $2.0M, an operating margin of -10524.3%. The quarter ended with a net loss of $2.1M.
Operating cash flow was −$1.4M. Non-cash charges added back $501K of share-based compensation. Working capital and other items added $129K.
Questions
What was Jupiter Neurosciences' revenue in the first quarter 2026?
Jupiter Neurosciences (JUNS) reported revenue of $19K for the first quarter 2026 (Q1 2026).